ViaLase
Empowering medical professionals with efficient, non-invasive glaucoma management through micron-resolution OCT image-guided femtosecond laser technology.
General Information
BounceWatch is an independent company data service, not affiliated with ViaLase. To contact ViaLase, visit vialase.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ViaLase compare?
A PDF of ViaLase and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ViaLase soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About ViaLase
Business keywords: glaucoma treatment, femtosecond laser technology, OCT imaging, non-invasive surgery, ophthalmology
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | $40.00M | 3 |
|
01 Apr 2024 |
| Debt Financing | $3.50M | - |
|
18 Jan 2024 |
| Series A | $27.29M | 3 |
|
19 Nov 2021 |
| Venture Round | $8.14M | - |
|
20 Mar 2019 |
ViaLase Alternatives & Competitors
View All Alternatives
Delivering comprehensive intraocular solutions and pre-surgical services for optimal cataract care.
BELKIN Vision is now part of Alcon. Follow Alcon for more updates.
FAQ About ViaLase
Source: BounceWatch company record for ViaLase, https://bouncewatch.com/company/vialase, updated 20 December 2024. When citing, please name BounceWatch and link this page.
